Kjems J, Zukauskaite R, Johansen J, Eriksen JG, Lassen P, Andersen E, Andersen M, Farhadi M, Overgaard J, Vogelius IR, Friborg JDistant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA studyActa Oncol. 2021 Nov;60(11):1472-1480 2021
Christiansen RL, Johansen J, Zukauskaite R, Hansen CR, Bertelsen AS, Hansen O, Mahmood F, Brink C, Bernchou UAccuracy of automatic structure propagation for daily magnetic resonance image-guided head and neck radiotherapyActa Oncol . 2021 May;60(5):589-597 2021
Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard JTreatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohortsInt J Cancer . 2022 Apr 15;150(8):1329-1340 2022
Sharma MB, Jensen K, Friborg J, Smulders B, Andersen E, Samsøe E, Johansen J, Hansen CR, Andersen M, Nielsen MS, Filtenborg MV, Ren J, Korreman SS, Overgaard J, Grau CTarget coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008-2015. A DAHANCA studyActa Oncol . 2022 Feb;61(2):120-126 2022
Kristensen MH, Hansen CR, Zukauskaite R, Johansen J, Samsøe E, Maare C, Holm AIS, Eriksen JGCo-registration of radiotherapy planning and recurrence scans with different imaging modalities in head and neck cancerPhys Imaging Radiat Oncol . 2022 Jun 30;23:80-84 2022
Hansen CR, Price G, Field M, Sarup N, Zukauskaite R, Johansen J, Eriksen JG, Aly F, McPartlin A, HollowayOpen-source distributed learning validation for a larynx cancer survival model following radiotherapy Radiother Oncol. 2022 Aug;173:319-326 2022
Kristian Hastoft Jensen Ivan Vogelius, Claus Ernst Moser , Elo Andersen, Jesper Grau Eriksen, Jørgen Johansen , Mohammad Farhadi, Maria Andersen, Jens Overgaard, Jeppe FriborgBloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group databaseBr J Cancer. 2021 Aug;125(3):458-464 2021
Sharma MB, Jensen K, Urbak SF, Funding M, Johansen J, Bechtold D, Amidi A, Eskildsen SF, Jørgensen JOL, Grau CA multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancerRadiother Oncol. 2020 Oct;151:58-65 2020
Sharma MB, Jensen K, Amidi A, Eskildsen SF, Johansen J, Grau CLate toxicity in the brain after radiotherapy for sinonasal cancer: Neurocognitive functioning, MRI of the brain and quality of lifeClin Transl Radiat Oncol. 2020 Sep 12;25:52-60. 2020
Christiansen RL, Gornitzka J, Andersen P, Nielsen M, Johnsen L, Bertelsen A, Zukauskaite R, Johansen J, Hansen CRAwareness and surveillance of radiation treatment schedules reduces head and neck overall treatment timeTech Innov Patient Support Radiat Oncol. 2019 Feb 23;9:26-30 2019
Saksø M, Primdahl H, Johansen J, Nowicka-Matus K, Overgaard J; DAHANCADAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051)Acta Oncol. 2020 Feb;59(2):208-211 2020
Holländer-Mieritz C, Johansen J, Taarnhøj GA, Johansen C, Vogelius IR, Kristensen CA, Pappot HSystematic use of patient reported outcome during radiotherapy for head and neck cancer: study protocol for the national DAHANCA 38 trialActa Oncol. 2020 May;59(5):603-607 2020
Hansen CR, Bertelsen A, Zukauskaite R, Johnsen L, Bernchou U, Thwaites DI, Eriksen JG, Johansen J, Brink CPrediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohortRadiother Oncol. 2020 Jun;147:15-21. 2020
Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, Smulders B, Andersen E, Nielsen MS, Eriksen JG, Petersen JBB, Elstrøm UV, Holm AI, Farhadi M, Morthorst MH, Skyt PS, Overgaard J, Grau CThe danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines.Radiother Oncol. 2020 Aug 8;151:149-151. 2020
Saksø M, Mortensen LS, Primdahl H, Johansen J, Kallehauge J, Hansen CR, Overgaard JInfluence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).Radiother Oncol. 2020 Aug 14;151:126-133. 2020
Jensen KH, Vogelius I, Kristensen CA, Andersen E, Overgaard J, Eriksen JG, Primdahl H, Johansen J, Farhadi M, Andersen M, Friborg JEarly Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database.Clin Oncol (R Coll Radiol) . 2020 Jul 19;S0936-6555(20)30286-7. 2020
Saksø M, Andersen E, Bentzen J, Andersen M, Johansen J, Primdahl H, Overgaard J, Eriksen JG.A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma.Acta Oncol. 2019 Oct;58(10):1495-1501. 2019
Zukauskaite R, Hansen CR, Grau C, Samsøe E, Johansen J, Petersen JBB, Andersen E, Brink C, Overgaard J, Eriksen JGLocal recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins.Radiother Oncol. 2018 Jan;126(1):48-55. 2018
Boysen AK, Sørensen BS, Lefevre AC, Abrantes R, Johansen JS, Jensen BV, Schou JV, Larsen FO, Nielsen D, Taflin H, Gustavson B, Wettergren Y, Sorensen BS, Ree AH, Dueland S, Pallisgaard N, Spindler KLMethodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer.Clin Chim Acta. 2018 Dec;487:107-111. 2018
Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen
L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl
H, Bratland Å, Kristensen CA, Andersen M, Eriksen JG,
Overgaard JNTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy.Acta Oncol. 2019 Oct;58(10):1410-1415. 2019
Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen JOsteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.Acta Oncol. 2019 Oct;58(10):1373-1377. 2019
Holländer-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot HComparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.Acta Oncol. 2019 May;58(5):603-609. 2019
Zukauskaite R, Rumley CN, Hansen CR, Jameson MG, Trada Y, Johansen J, Gyldenkerne N, Eriksen JG, Aly F, Christensen RL, Lee M, Brink C, Holloway LDelineation uncertainties of tumour volumes on MRI of head and neck cancer patientsClinical and Translational Radiation Oncology. September 2022, Pages 121-126 2022
Carlsen AH, Eriksen JG, Godballe C, Johansen J, Sørensen JA, Bjørndal K.Impact of age, comorbidity, and WHO performance status on delay of treatment in patients undergoing fast-track work-up for head and neck cancer.J Geriatr Oncol. 2019 Mar;10(2):259-264 2018
Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee A, Maingon P, Mäkitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Składowski K, Tribius S, Waldron J, Wee J, Yao M, Yom SS, Zimmermann F, Grau CDelineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelinesRadiother Oncol. 2018 Jan;126(1):3-24 2018
Hansen CR, Johansen J, Samsøe E, Andersen E, Petersen JBB, Jensen K, Andersen LJ, Sand HMB, Bertelsen AS, Grau CConsequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapyRadiother Oncol. 2018 Jan;126(1):43-47 2018
Mäkitie A, Ruuskanen M, Bentzen J, Brun E, Gebre-Medhin M, Friesland S, Marsk E, Hammarstedt-Nordenvall L, Gille E, Reizenstein J, Adell G, Farnebo L, Rzepecki J, Haugen H, Söderström K, Zackrisson B, Bergström S, Lödén B, Cederblad L, Laurell G, Smeland E, Folkvard Evensen J, Lund JÅ, Tøndel H, Karlsdottir Å, Jóhannsson J, Johansen J, Kristensen CA, Jensen K, Andersen LJ, Koivunen P, Korpela M, Voutilainen L, Wigren T, Minn H, Joensuu H, Overgaard J, Saarilahti KThe management and survival outcomes of nasopharyngeal cancer in the Nordic countriesActa Oncol. 2018 Apr;57(4):557-560. 2018
Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C.DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.Radiother Oncol. 2018 Apr;127(1):12-19 2018
Roennegaard AB, Rosenberg T, Bjørndal K, Sørensen JA, Johansen J, Godballe C.The Danish Head and Neck Cancer fast-track program: a tertiary cancer centre experience.Eur J Cancer. 2018 Feb;90:133-139 2018
Rohde M, Nielsen AL, Johansen J, Sørensen JA, Diaz A, Asmussen JT, Gerke O, Thomassen A, Gyldenkerne N, Døssing H, Bjørndal K, Høilund-Carlsen PF, Godballe C. Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):613-621. 2018
Rohde M, Nielsen AL, Pareek M, Johansen J, Sørensen JA, Diaz A, Nielsen MK, Christiansen JM, Asmussen JT, Nguyen N, Gerke O, Thomassen A, Alavi A, Høilund-Carlsen PF, Godballe CA PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell CarcinomaJ Nucl Med. 2018 Apr;59(4):575-581 2018
Schou JV, Larsen FO, Sørensen BS, Abrantes R, Boysen AK, Johansen JS, Jensen BV, Nielsen DL, Spindler KL.Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.Ann Oncol. 2018 Mar 1;29(3):610-615 2018
Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J. DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)Acta Oncol. 2019 Oct;58(10):1502-1505 2019
Rohde M, Nielsen AL, Johansen J, Sørensen JA, Diaz A, Pareek M, Asmussen JT, Gerke O, Thomassen A, Gyldenkerne N, Døssing H, Bjørndal K, Høilund-Carlsen PF, Godballe CUpfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinomaOral Oncol. 2019 Jul;94:1-7 2019
Rohde M, Nielsen AL, Pareek M, Johansen J, Sørensen JA, Diaz A, Nielsen MK, Christiansen JM, Asmussen JT, Nguyen N, Gerke O, Thomassen A, Alavi A, Høilund-Carlsen PF, Godballe C PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma J Nucl Med. 2019 May;60(5):592-599 2019
Porceddu SV, Daniels C, Yom SS, Liu H, Waldron J, Gregoire V, Moore A, Veness M, Yao M, Johansen J, Mehanna H, Rischin D, Le QTHead and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):641-651 2020
Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SSPractice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementRadiother Oncol. 2020 Oct;151:314-321 2020
Carsuzaa F, Lapeyre M, Gregoire V, Maingon P, Beddok A, Marcy PY, Salleron J, Coutte A, Racadot S, Pointreau Y, Graff P, Beadle B, Benezery K, Biau J, Calugaru V, Castelli J, Chua M, Di Rito A, Dore M, Ghadjar P, Huguet F, Jardel P, Johansen J, Kimple R, Krengli M, Laskar S, Mcdowell L, Nichols A, Tribius S, Valduvieco I, Hu C, Liem X, Moya-Plana A, D'onofrio I, Parvathaneni U, Takiar V, Orlandi E, Psyrri A, Shenouda G, Sher D, Steuer C, Shan Sun X, Tao Y, Thomson D, Tsai MH, Vulquin N, Gorphe P, Mehanna H, Yom SS, Bourhis J, Thariat J.Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensusRadiother Oncol. 2021 Jul;160:140-147 2021
Eriksen JG, Johansen J, Godballe C, Kjærgaard T, Primdahl H, Charabi B, Andersen E, Farhadi M, Kristensen CA, Lyhne N, Andersen M, Grau C, Høyrup M, Hvass SA, Overgaard J Danish Head & Neck Cancer group (DAHANCA) kvalitetsdatabase - Resumé af årsrapport 2020Ugeskr Læg 2021. 2021
Filtenborg MV, Lilja-Fischer JK, Sharma MB, Primdahl H, Kjems J, Plaschke CC, Wessel I, Kristensen CA, Andersen M, Andersen E, Godballe C, Johansen J, Overgaard J, Petersen KBSinonasal cancer in Denmark 2008-2015: a population-based phase-4 cohort study from DAHANCAActa Oncol. 2021 Mar;60(3):333-342 2021
Westergaard-Nielsen M, Godballe C, Eriksen JG, Larsen SR, Kiss K, Agander T, Ulhøi BP, Charabi B, Klug TE, Jacobsen H, Johansen J, Kristensen CA, Andersen E, Andersen M, Andreasen S, Bjørndal K Salivary gland carcinoma in Denmark: a national update and follow-up on incidence, histology, and outcomeEur Arch Otorhinolaryngol. 2021 Apr;278(4):1179-1188 2021
Singers Sørensen B, Krzysztof Sitarz M, Ankjærgaard C, Johansen J, Andersen CE, Kanouta E, Overgaard C, Grau C, Poulsen P In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASHRadiother Oncol. 2022 Feb;167:109-115 2022
Olsen MH, Frederiksen K, Lassen P, Rotbøl C, Kjaer TK, Johansen J, Primdahl H, Andersen E, Kristensen CA, Andersen M, Farhadi M, Overgaard J, Dalton SO; Danish Head and Neck Cancer Group (DAHANCA)Association of Smoking, Comorbidity, Clinical Stage, and Treatment Intent With Socioeconomic Differences in Survival After Oropharyngeal Squamous Cell Carcinoma in DenmarkJAMA Netw Open. 2022 Dec 1;5(12):e2245510 2022
Humbert-Vidan L, Hansen CR, Fuller CD, Petit S, van der Schaaf A, van Dijk LV, Verduijn GM, Langendijk H, Muñoz-Montplet C, Heemsbergen W, Witjes M, Mohamed ASR, Khan AA, Marruecos Querol J, Oliveras Cancio I, Patel V, King AP, Johansen J, Guerrero Urbano T A multi-institutional retrospective case-control cohort investigating PREDiction models for mandibular OsteoRadioNecrosis in head and neck cancer (PREDMORN)Radiother Oncol. 2022 Nov;176:99-100 2022
Hansen CR, Price G, Field M, Sarup N, Zukauskaite R, Johansen J, Eriksen JG, Aly F, McPartlin A, Holloway L, Thwaites D, Brink CLarynx cancer survival model developed through open-source federated learningRadiother Oncol. 2022 Nov;176:179-186 2022
Forner LE, Dieleman FJ, Shaw RJ, Kanatas A, Butterworth CJ, Kjeller G, Alsner J, Overgaard J, Hillerup S, Hyldegaard O, Arnell P, von Buchwald C, Kaanders JHAM, Smeele LE, Specht L, Johansen J, Witjes MJH, Merkx MAW, Jansen ECHyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1.Radiother Oncol. 2022 Jan;166:137-144 2022
Filtenborg MV, Lilja-Fischer JK, Sharma MB, Primdahl H, Kjems J, Plaschke CC, Charabi BW, Kristensen CA, Andersen M, Andersen E, Godballe C, Johansen J, Overgaard J, Petersen KBNasal vestibule squamous cell carcinoma: a population-based cohort study from DAHANCAActa Oncol. 2022 Feb;61(2):127-133 2022